273 related articles for article (PubMed ID: 15773274)
1. Cost of single-vessel and multivessel coronary drug-eluting stenting: comparison to the DRG funding level.
Varani E; Balducelli M; Gatti C; Tesselli MR; Vecchi G; Maresta A
Ital Heart J; 2005 Jan; 6(1):52-8. PubMed ID: 15773274
[TBL] [Abstract][Full Text] [Related]
2. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease.
Griffiths H; Bakhai A; West D; Petrou M; De Souza T; Moat N; Pepper J; Di Mario C
Eur J Cardiothorac Surg; 2004 Sep; 26(3):528-34. PubMed ID: 15302047
[TBL] [Abstract][Full Text] [Related]
5. Potential shift from coronary bypass surgery to percutaneous coronary intervention for multivessel disease and its economic impact in the drug-eluting stent era.
Poulin F; Rinfret S; Gobeil F
Can J Cardiol; 2007 Dec; 23(14):1139-45. PubMed ID: 18060100
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.
Krenn L; Kopp C; Glogar D; Lang IM; Delle-Karth G; Neunteufl T; Kreiner G; Kaider A; Bergler-Klein J; Khorsand A; Nikfardjam M; Laufer G; Maurer G; Gyöngyösi M
Catheter Cardiovasc Interv; 2014 Dec; 84(7):1029-39. PubMed ID: 24403120
[TBL] [Abstract][Full Text] [Related]
7. [Can PCI with drug-eluting stents replace coronary artery bypass surgery? A comparative economic analysis regarding both therapeutic options based on clinical 12-month data reflecting the German social health care insurance system].
Fricke FU; Silber S
Herz; 2005 Jun; 30(4):332-8. PubMed ID: 15965811
[TBL] [Abstract][Full Text] [Related]
8. Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical revascularization in patients with multivessel coronary artery disease: one-year clinical results and total treatment costs.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Invasive Cardiol; 2007 Nov; 19(11):469-75. PubMed ID: 17986722
[TBL] [Abstract][Full Text] [Related]
9. Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.
Cohen DJ; Lavelle TA; Van Hout B; Li H; Lei Y; Robertus K; Pinto D; Magnuson EA; Mcgarry TF; Lucas SK; Horwitz PA; Henry CA; Serruys PW; Mohr FW; Kappetein AP
Catheter Cardiovasc Interv; 2012 Feb; 79(2):198-209. PubMed ID: 21542113
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial.
Magnuson EA; Farkouh ME; Fuster V; Wang K; Vilain K; Li H; Appelwick J; Muratov V; Sleeper LA; Boineau R; Abdallah M; Cohen DJ;
Circulation; 2013 Feb; 127(7):820-31. PubMed ID: 23277307
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.
Varani E; Guastaroba P; Di Tanna GL; Saia F; Balducelli M; Campo G; Vignali L; Rossi R; Manari A; Piovaccari G; De Palma R; Marzocchi A
EuroIntervention; 2010 Apr; 5(8):953-61. PubMed ID: 20542781
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
[TBL] [Abstract][Full Text] [Related]
14. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
[TBL] [Abstract][Full Text] [Related]
15. Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting.
Birim Ö; Bogers AJ; Kappetein AP
J Cardiovasc Surg (Torino); 2012 Oct; 53(5):641-50. PubMed ID: 22252542
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.
Ariyaratne TV; Yap CH; Ademi Z; Rosenfeldt F; Duffy SJ; Billah B; Reid CM
Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):261-270. PubMed ID: 29474722
[TBL] [Abstract][Full Text] [Related]
17. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
[TBL] [Abstract][Full Text] [Related]
18. Cost comparison of four revascularisation procedures for the treatment of multivessel coronary artery disease.
Wang X; Rokoss M; Dyub A; Gafni A; Lamy A
J Med Econ; 2008; 11(1):119-34. PubMed ID: 19450114
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
